Comments
Loading...

Vor Biopharma

VORNASDAQ
Logo brought to you by Benzinga Data
$0.934200
-0.02-2.48%
At Close: -
$0.934100
~0-0.01%
After Hours: 5:12 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$22.00
Lowest Price Target1
$3.00
Consensus Price Target1
$12.55

Vor Biopharma (NASDAQ:VOR) Stock, Analyst Ratings, Price Targets, Forecasts

Vor Biopharma Inc has a consensus price target of $12.55 based on the ratings of 10 analysts. The high is $22 issued by Baird on March 24, 2023. The low is $3 issued by Barclays on August 14, 2024. The 3 most-recent analyst ratings were released by JMP Securities, HC Wainwright & Co., and Barclays on September 6, 2024, September 6, 2024, and August 14, 2024, respectively. With an average price target of $10.83 between JMP Securities, HC Wainwright & Co., and Barclays, there's an implied 1059.76% upside for Vor Biopharma Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
2
Mar
1
Apr
2
May
1
Aug
0
0
0
0
Sep
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

JMP Securities
HC Wainwright & Co.
Barclays
Oppenheimer
Wedbush

1calculated from analyst ratings

Analyst Ratings for Vor Biopharma

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Vor Biopharma (VOR) stock?

A

The latest price target for Vor Biopharma (NASDAQ:VOR) was reported by JMP Securities on September 6, 2024. The analyst firm set a price target for $12.00 expecting VOR to rise to within 12 months (a possible 1184.66% upside). 13 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Vor Biopharma (VOR)?

A

The latest analyst rating for Vor Biopharma (NASDAQ:VOR) was provided by JMP Securities, and Vor Biopharma reiterated their market outperform rating.

Q

When was the last upgrade for Vor Biopharma (VOR)?

A

There is no last upgrade for Vor Biopharma

Q

When was the last downgrade for Vor Biopharma (VOR)?

A

There is no last downgrade for Vor Biopharma.

Q

When is the next analyst rating going to be posted or updated for Vor Biopharma (VOR)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Vor Biopharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Vor Biopharma was filed on September 6, 2024 so you should expect the next rating to be made available sometime around September 6, 2025.

Q

Is the Analyst Rating Vor Biopharma (VOR) correct?

A

While ratings are subjective and will change, the latest Vor Biopharma (VOR) rating was a reiterated with a price target of $12.00 to $12.00. The current price Vor Biopharma (VOR) is trading at is $0.93, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch